AVJ16
AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 with a good affinity of Kd of 1.4μM. AVJ16 interferes with IGF2BP1 binding target mRNA to regulate gene expression and translation[1].
Product Specifications
CAS Number
2775241-92-2
UNSPSC
12352005
Target
Apoptosis; Insulin Receptor
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/avj16.html
Concentration
10mM
Purity
99.60
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(N1CCN(CC1)C2=CC3=C(OCO3)C=C2)C4=CC=C(C=C4)CN5C(CO)=CC6=C5C=CC=C6
Molecular Formula
C28H27N3O4
Molecular Weight
469.53
References & Citations
[1]Singh A, et al. Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent[J]. European Journal of Cancer, 2022, 174: S104-S105.|[2]Wallis N, et al. AVJ16 inhibits the RNA binding protein IGF2BP1 in lung adenocarcinomas and prevents tumor growth in mice[J]. bioRxiv, 2024: 2024.08. 15.608038.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
F1L169, S001 1x 0.1 mg
STAR FLUOR 770 Goat anti-Mouse, highly cross adsorbed
Sign In for Pricing
View Details KZMC021 20x 0.5 mL
Influenza Rapid Test Verification Panel (20 X 0.5 mL)
Sign In for Pricing
View Details